Showing results (151-160 of 170) with videos related to
Sort By:
Pageof 17
Annals of Internal Medicine|February 1, 1993
Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosineM A Dimopoulos, H Kantarjian, E Estey, et al.Bone Marrow Transplantation|July 28, 2009
CR represents an early index of potential long survival in multiple myelomaM Wang, K Delasalle, L Feng, et al.British Journal of Haematology|May 12, 1998
Prognostic value of cytogenetics in multiple myelomaC Seong, K Delasalle, K Hayes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myelomaL A Moulopoulos, M A Dimopoulos, T L Smith, et al.Blood|August 15, 1990
High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myelomaB Barlogie, S Jagannath, D O Dixon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosineM A Dimopoulos, H Kantarjian, D Weber, et al.Blood|November 1, 1990
Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factorsS Jagannath, B Barlogie, K Dicke, et al.American Journal of Clinical Pathology|October 17, 2001
Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical courseA Mansoor, L J Medeiros, D M Weber, et al.British Journal of Cancer|June 23, 2005
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cellsM Amit-Vazina, S Shishodia, D Harris, et al.Blood|October 15, 1993
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myelomaM A Dimopoulos, R Alexanian, D Przepiorka, et al.Pageof 17